|
Q3 2021
Filed on Nov 15, 2021
|
268,583
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
39
|
$17.11 - $24.49
$667 - $955
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
6,856
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
527
|
$19.74 - $21.95
$10.4K - $11.6K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
16,674
|
$152.99 - $167.43
$2.55M - $2.79M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
29
|
$20.8 - $26.96
$603 - $782
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
100,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
3,738,001
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
48,490
|
$101.48 - $127.22
$4.92M - $6.17M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
120,097
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1,673
|
$58.29 - $71.81
$97.5K - $120K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
103,725
|
$35.09 - $38.8
$3.64M - $4.02M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
139
|
$12.33 - $20.4
$1.71K - $2.84K
|
|
Catabasis Pharmaceuticals In
|
Q3 2021
Filed on Nov 15, 2021
|
233
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
2,799
|
$86.01 - $97.47
$241K - $273K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1,587
|
$19.46 - $22.34
$30.9K - $35.5K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
111,032
|
$12.03 - $18.25
$1.34M - $2.03M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
103
|
$47.13 - $56.03
$4.85K - $5.77K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
38
|
$32.26 - $44.77
$1.23K - $1.7K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
15
|
$27.04 - $31.6
$406 - $474
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
50,001
|
$3.89 - $11.66
$195K - $583K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
130,426
|
$62.44 - $63.91
$8.14M - $8.34M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
285
|
$3.1 - $4.32
$884 - $1.23K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
63
|
$38.32 - $44.11
$2.41K - $2.78K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
367,223
|
$17.38 - $21.54
$6.38M - $7.91M
|
|
Cerevel Therapeutics Hldng I
|
Q3 2021
Filed on Nov 15, 2021
|
283,333
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
25,077
|
$13.5 - $16.15
$339K - $405K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
89
|
$7.9 - $21.51
$703 - $1.91K
|
|
Dragoneer Growth Oppty Corp
|
Q3 2021
Filed on Nov 15, 2021
|
300,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
35,527
|
$16.82 - $25.75
$598K - $915K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
12,000
|
$18.12 - $28.5
$217K - $342K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
9,803
|
$32.64 - $38.64
$320K - $379K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
9,219
|
$7.97 - $17.25
$73.5K - $159K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
75,623
|
$5.1 - $9.39
$386K - $710K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
15,000
|
$6.02 - $12.46
$90.3K - $187K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
6,654
|
$7.17 - $18.85
$47.7K - $125K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
50,000
|
$23.19 - $25.22
$1.16M - $1.26M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
300,000
|
$9.73 - $9.9
$2.92M - $2.97M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
19
|
$30.95 - $120.97
$588 - $2.3K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
76
|
$6.71 - $14.55
$510 - $1.11K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
126
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
31
|
$19.88 - $41.62
$616 - $1.29K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
251
|
$1.74 - $2.6
$437 - $653
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
9,817
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
26,395
|
$38.34 - $41.96
$1.01M - $1.11M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
222
|
$40.5 - $66.99
$8.99K - $14.9K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
16,656
|
$7.09 - $10.71
$118K - $178K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
154
|
$5.34 - $9.87
$822 - $1.52K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
40,225
|
$9.61 - $12.07
$387K - $486K
|
|